Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additional effect of tiotropium bromide on exercise tolerance in COPD patients (pilot study)
2010-019047-19Phase 4Terminated
- Sponsor
- Pneumologia c/o Villa Pineta
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Pneumologia c/o Villa Pineta. Primary endpoint: Absolute change of exercise tolerance. Started May 2010; status: terminated.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-019047-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019047-19.